Holen Sie sich die Stockscreener-App
0.32
3.19%
0.0099
Vorhandelsmarkt:
.32
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC Advances Patient Enrollment in Alzheimer's Clinical Trial - GuruFocus
IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout - Finviz
IGC Pharma Reaches 80% Enrollment in Phase 2 CALMA Trial, Entering Final Phase Ahead of Enrollment Completion and Data Readout (2026-04-14) - Seeking Alpha
What is IGC Pharma Incs valuation compared to sector2026 Fundamental Recap & Reliable Breakout Forecasts - baoquankhu1.vn
IGC Pharma (IGC) price target increased by 10.34% to 4.08 - MSN
New to The Street Broadcasts on Bloomberg TV, Featuring IGC, VVOS, ACXP, and EQX - National Today
New to The Street Broadcasts on Bloomberg Television at 6:30 PM EST Featuring IGC Pharma (IGC), Vivos Therapeutics (VVOS), Acurx Pharmaceuticals (ACXP), and Equinox Gold (EQX) - Idaho Statesman
IGC Pharma Share Price Target and Forecast - Investing.com India
Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.25, Citing Clinical Progress and Upcoming Catalysts - 富途牛牛
IGC Pharma (NYSEAMERICAN:IGC) Given New $5.25 Price Target at Ascendiant Capital Markets - Defense World
Analyst lifts IGC Pharma target to $5.25 as Alzheimer’s trial advances - Stock Titan
IGC Pharma (NYSEAMERICAN:IGC) Shares Up 0.9% – Still a Buy? - Defense World
IGC Stock Price, Quote & Chart | IGC PHARMA INC (NYSEARCA:IGC) - ChartMill
IGC Pharma Adds Tandem Clinical Research to the CALMA Trial for Agitation in Alzheimer's Disease - marketscreener.com
IGC Pharma Expands Clinical Trial with New Site Activation - GuruFocus
Director at IGC Pharma (IGC) receives 170,000 shares from RSUs - Stock Titan
IGC Pharma (IGC) CEO acquires 706,409 shares via equity awards - Stock Titan
IGC Pharma (IGC) director gains 130K shares from RSU conversions - Stock Titan
IGC Pharma (IGC) PFO Claudia Grimaldi exercises RSUs and options for more shares - Stock Titan
IGC.WS (India Globalization Capital) PB Ratio : (As of Apr. 03, 2026) - GuruFocus
How does IGC Pharma Inc perform in inflationary periodsWeekly Gains Report & Technical Buy Zone Confirmations - baoquankhu1.vn
IGC Pharma Launches National Media Partnership to Boost Visibility - The Globe and Mail
IGC Pharma Launches Strategic National Media Partnership with Ne - GuruFocus
Aug Breakouts: Should I trade or invest in IGC Pharma Inc2026 Rallies & Entry Point Strategy Guides - baoquankhu1.vn
Signal Recap: What is IGC Pharma Incs valuation compared to sectorQuarterly Portfolio Review & Comprehensive Market Scan Insights - baoquankhu1.vn
Performance Recap: What is IGC Pharma Incs book value per shareMarket Growth Review & Stock Market Timing Techniques - baoquankhu1.vn
IGC Pharma launches 12-part national media campaign with New to The Street to boost investor awareness - TradingView — Track All Markets
IGC Pharma (NYSE: IGC) inks 12-part New to The Street deal - Stock Titan
Aug Shorts: What is IGC Pharma Incs book value per share2026 Trade Ideas & Community Verified Trade Alerts - baoquankhu1.vn
IGC Pharma Partners with New to The Street for National Media Campaign - National Today
IGC Pharma Launches Strategic National Media Partnership with New to The Street to Expand Investor Awareness - biospace.com
IGC Pharma Launches Strategic National Media Partnership With New to The Street to Expand Investor Awareness - 富途牛牛
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates - MSN
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - The Joplin Globe
Macro Review: Is IGC Pharma Inc likely to announce a buybackChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
If You Invested $1,000 in IGC Pharma Inc (IGC) - Stock Titan
Growth Report: Does IGC Pharma Inc stock benefit from AI growthEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Ascendiant Capital maintains IGC Pharma (IGC) buy recommendation - MSN
Fund Flows: Can IGC Pharma Inc ride the EV wave2026 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
India Globalization Capital, Inc.: Fundamental Analysis and Financial Ratings | IGC | US45408X3089 - marketscreener.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Hastings Tribune
IGC Achieves Major Milestone in Alzheimer's Trial Amid Financial Loss - GuruFocus
IGC Pharma’s AI-Driven Innovations and Patent Portfolio for Alzheimer’s Disease and Neuropsychiatric Treatments - Minichart
IGC to Showcase AI Platform for Alzheimer's Research at 2026 Con - GuruFocus
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):